an employee-owned company
The development of a vaccine for the novel coronavirus SARS-CoV-2 has captured—perhaps uniquely—the attention of a global audience of scientists, medical doctors, politicians, and the general public. However, identifying a viable vaccine candidate is only one of the first, of... 
